Maralixibat Takes Out the Itch of Rare Liver Disease Ileal bile acid transporter inhibitor could become second drug for PFIC Nov 09, 2022
Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devices Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
Pebbled Skin and Excessive Hair Growth on a 5-Year-Old's Back Just two of the multiple symptoms that began to emerge shortly after birth Oct 24, 2022
Dupilumab Gets First FDA-Approved Indication for Prurigo Nodularis Significant improvement in itch and nodules at 24 weeks seen in two randomized trials Sep 29, 2022
Immunotherapy First for BRAF Melanoma Edges Out Targeted Combination "Clinically meaningful" improvement in 2- and 3-year survival Sep 28, 2022
Make the Diagnosis: His Skin Is Slacking Off A 43-year-old man presented to the doctor with a rash that had developed on his trunk over the last couple of days. Sep 28, 2022
Appointment Wait Times Continue to Rise Amid Concerns of Physician Shortages New survey finds that wait times increased by 8% across four specialties since 2017 Sep 16, 2022
Make the Diagnosis: Increased Hair Loss and 'White Bulbs' -- What’s Up? A 55-year-old woman visited her doctor after noticing that the hair on her scalp was falling out at an increased rate over the last 3 months. Sep 14, 2022
What Caused This Rapidly Enlarging Facial Abscess? Expansion over several weeks necessitated timely diagnosis and ruling out mimicking conditions Sep 13, 2022
Neoadjuvant Anti-PD-1 Strategy Prevails Over Adjuvant in Resectable Melanoma Large increase in event-free survival with neoadjuvant plus adjuvant versus only adjuvant therapy Sep 13, 2022
Neoadjuvant Cemiplimab Active in Resectable Cutaneous Squamous Cell Carcinoma Pathologic complete responses seen in 63% of patients in phase II data Sep 12, 2022
Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Option More than 50% increase in 6-month PFS versus ipilimumab after progression on first-line anti-PD-1 Sep 12, 2022
First TYK2 Inhibitor for Psoriasis Wins FDA Approval Deucravacitinib significantly outperformed apremilast in two randomized trials Sep 11, 2022
First Approved Treatment for Generalized Pustular Psoriasis Spesolimab led to complete clearance of pustules within a week in more than half of patients Sep 07, 2022
Inflammation Marker May Spot Atopic Dermatitis Risk Early in Childhood Elevated TARC at 2 months more than quadrupled the likelihood of moderate-severe AD at 2 years Sep 06, 2022
Keytruda Plus T-VEC Falls Short in Unresectable Melanoma No significant survival benefit with combination, but certain patients lived longer Sep 02, 2022
Increased Health Spending When Private Equity Acquires Physician Practices Patient volume also increased, but whether patients are benefiting remains to be seen Sep 02, 2022
Can COVID-19 Cause Hair Loss? Shedding may be induced by COVID-related stress, but hair will grow back, experts say Aug 12, 2022
Study: Flares in Pustular Psoriasis Often Undertreated Drug firm hopes to bring new specific treatment to market Aug 10, 2022
Asian Psoriasis Patients Get Less Time With Dermatologists, Study Suggests Cross-sectional study shows Asian patients have shortest face-to-face visits Aug 03, 2022
What Caused Man's Saddle-Nose Deformity Years After Lymphoma Dx? Rare diagnosis points to need for thorough workup in patients with severe nasal congestion Aug 01, 2022
Are Skin Lesion Analyzers Ready for Prime Time? FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
BDCA2-Targeting Antibody May Be Effective for Cutaneous Lupus In small randomized trial, litifilimab shows superiority over placebo for skin disease activity Jul 27, 2022
How Monkeypox Can Present Like Common STIs Some cases involve just a single genital lesion, large multinational series shows Jul 26, 2022
TKI Plus Immunotherapy Active in Melanoma After Anti-PD-1 Progression More than a fifth of patients responded to lenvatinib-pembrolizumab combination Jul 26, 2022
Sexual Dysfunction, Hair Loss Among Long COVID Symptoms Wider range of post-COVID symptoms emerge than previously thought Jul 25, 2022
A Monkeypox Moment Let's use the lessons we learned from COVID-19 to battle this new disease threat Jul 25, 2022
Dear Acne: You've Ruined My Life, I Hate You Personifying acne, scarring provides new insight into psychosocial burden of condition Jul 22, 2022
Topical JAK Inhibitor OK'd for Repigmentation of Vitiligo Significantly more patients achieved 75%, 90% improvement Jul 19, 2022
Novel Nitric Oxide Gel Clears Kids' Molluscum Contagiosum Lesions Children may not need to "wait it out" for much longer, positive trial suggests Jul 13, 2022
Make the Diagnosis: She’s Too Young for Lines on Her Face A 9-year-old girl was brought to the doctor by her mother after noticing a rash that had developed on the girl's face over the past week. Jul 13, 2022
Chronic, Disfiguring Facial Rash With No Itching or Pain Female patient reports low quality of life after 10 years of treatments with no response Jul 11, 2022
Odevixibat Scratches the Itch of Kids' Rare Liver Disease Phase III trial showed reduced pruritus in progressive familial intrahepatic cholestasis Jul 08, 2022
Which Biologics Stick Longest for Psoriasis? British data highlight factors affecting drug longevity Jul 06, 2022
Does Sunlight Trigger Lupus? Analysis of data from major study suggests "yes," but falls short of clear conclusion Jun 22, 2022
Health Equity, Gun Violence Prevention Among Priorities for AMA's New President Jack Resneck, Jr., MD, talks about running "the race we're in" Jun 15, 2022
FDA Approves First Systemic Treatment for Alopecia Areata Four to 10 times as many patients met hair-regrowth endpoint with JAK inhibitor versus placebo Jun 13, 2022
Something Fishy About Tuna and Melanoma Risk Higher total fish intake linked with 22% higher risk of malignant tumors Jun 09, 2022
Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritis Phase II results suggest drug could outperform existing agents Jun 03, 2022
